Ring Relief Homeopathic Fast Dissolving Tablets

Manufacturer: TRP Company
Effective date: 2025-12-15
Label type: HUMAN OTC DRUG LABEL
Version: 13
Source: full-release
Hydrated at: 2026-06-01 02:35:56

Label at a glance#

ProductRing Relief

Active ingredientARNICA MONTANA, CALCIUM SULFIDE, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM SPORE, MERCURIUS SOLUBILIS, SALICYLIC ACID, SILICON DIOXIDE, ALLYLTHIOUREA

Label structure12 sections

Contacts and useful links#

PhoneLabel contact888-969-6855

Websitewww.thereliefproducts.com

www.thereliefproducts.com

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Arnica montana HPUS 6x, 30x
Hepar sulph calc HPUS 13x
Hypericum perforatum HPUS 6x, 30x
Lycopodium clavatum HPUS 12x
Mercurius sol HPUS 13x
Salicylicum acidum HPUS 6x
Silicea HPUS 13x
Thiosinaminum HPUS 6x

OTC - PURPOSE SECTION

Arnica montana HPUS - Buzzing, Chirping
Hepar sulph calc HPUS - Noise sensitivity
Hypericum perforatum HPUS - Nerve sensitivity
Lycopodium clavatum HPUS - Pounding, wax buildup
Mercurius sol HPUS - Discomfort
Salicylicum acidum HPUS - Ringing, Buzzing
Silicea HPUS - Roaring
Thiosinaminum HPUS - Ringing (Tinnitus)

INDICATIONS & USAGE SECTION

Uses*
According to homeopathic indications, these ingredients temporarily relieve Tinnitus symptoms such as: • Ringing • Buzzing • Roaring • Nerve and Noise Sensitivity • Pounding • Discomfort • Wax buildup after serious causes have been ruled out by a physician.

*These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.

WARNINGS SECTION

Warnings:

A PHYSICIAN SHOULD ALWAYS BE CONSULTED TO RULE OUT SERIOUS CAUSES.

This product is intended to complement, not replace, standard medical treatment.
Initial worsening of symptoms may occur.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

WARNINGS SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

OTC - STOP USE SECTION

Stop use and ask a doctor if:

You experience ear pain or worsening symptoms.
Symptoms last longer than 7 days.

DOSAGE & ADMINISTRATION SECTION

Directions

Suitable for adults and children ages 2 and over.
Children under the age of 2: Consult a physician before use.
Dissolve entire tablet under tongue.
Do not chew or swallow whole.
Take 1 tablet 3 times a day or as directed by a physician.
Use up to 6 times a day as needed.
Take at least 10 minutes before or at least 10 minutes after eating or drinking.
Homeopathic remedies may not be effective for everyone.
May take up to 60 days to see results.

SPL UNCLASSIFIED SECTION

Other information

There are no known contraindications.
Active ingredients are micro-diluted in accordance with the Homeopathic Pharmacopoeia of the United States and are therefore non-toxic with no known side effects.
Store in a cool dark location.
Ring Relief Fast Disolving Tablets are homeopathic dilutions: see www.thereliefproducts.com for details.

INACTIVE INGREDIENT SECTION

Inactive Ingredients
Advantol® 300, Lactose, Magnesium Stearate, Mannitol, Microcrystalline Cellulose.

OTC - QUESTIONS SECTION

Questions or comments? 888-969-6855
www.thereliefproducts.com

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Carton

Label

Product Linked Resources#

Resource, Code type, Value table
Resource	Code type	Value	Equivalent identifiers	Source image
Barcode	EAN-13	0858961001150	GTIN-13: 0858961001150 EAN-13: 0858961001150 GTIN-12: 858961001150 UPC-A: 858961001150 GTIN storage (14 digits): 00858961001150	TRP_NE_RR_FDT_70ct_CTN_9_15_23_r2.jpg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
17312-023-14	Ring Relief	70 in 1 BOTTLE	TABLET, ORALLY DISINTEGRATING	70		13
17312-023-14	Ring Relief	1 in 1 PACKAGE	TABLET, ORALLY DISINTEGRATING	1		13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ALLYLTHIOUREA	ACTIVE INGREDIENT	706IDJ14B7	6
ARNICA MONTANA	ACTIVE INGREDIENT	O80TY208ZW	6
CALCIUM SULFIDE	ACTIVE INGREDIENT	1MBW07J51Q	6
HYPERICUM PERFORATUM	ACTIVE INGREDIENT	XK4IUX8MNB	6
LYCOPODIUM CLAVATUM SPORE	ACTIVE INGREDIENT	C88X29Y479	6
MERCURIUS SOLUBILIS	ACTIVE INGREDIENT	324Y4038G2	6
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	6
SILICON DIOXIDE	ACTIVE INGREDIENT	ETJ7Z6XBU4	6
ALLYLTHIOUREA	ACTIVE MOIETY	706IDJ14B7	6
ARNICA MONTANA	ACTIVE MOIETY	O80TY208ZW	6
CALCIUM SULFIDE	ACTIVE MOIETY	1MBW07J51Q	6
COLLOIDAL SILICON DIOXIDE	ACTIVE MOIETY	ETJ7Z6XBU4	6
HYPERICUM PERFORATUM	ACTIVE MOIETY	XK4IUX8MNB	6
LYCOPODIUM CLAVATUM SPORE	ACTIVE MOIETY	C88X29Y479	6
MERCURIUS SOLUBILIS	ACTIVE MOIETY	324Y4038G2	6
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	6
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	6
COPOVIDONE	INACTIVE INGREDIENT	D9C330MD8B	6
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	6
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	6
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	6
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	6
SORBITOL	INACTIVE INGREDIENT	506T60A25R	6

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

Ring Relief
ARNICA MONTANA - CALCIUM SULFIDE - HYPERICUM PERFORATUM - LYCOPODIUM CLAVATUM SPORE - MERCURIUS SOLUBILIS - SALICYLIC ACID - SILICON DIOXIDE - ALLYLTHIOUREA -
MANNITOL
SORBITOL
CROSPOVIDONE
CELLULOSE, MICROCRYSTALLINE
COPOVIDONE
LACTOSE
MAGNESIUM STEARATE
ARNICA MONTANA
CALCIUM SULFIDE
HYPERICUM PERFORATUM
LYCOPODIUM CLAVATUM SPORE
MERCURIUS SOLUBILIS
SALICYLIC ACID
SILICON DIOXIDE
ALLYLTHIOUREA

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
17312-023	17312-023-14

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
MANNITOL	3OWL53L36A	IACT
SORBITOL	506T60A25R	IACT
CROSPOVIDONE	68401960MK	IACT
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
COPOVIDONE	D9C330MD8B	IACT
LACTOSE	J2B2A4N98G	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
ARNICA MONTANA	O80TY208ZW	ACTIB
CALCIUM SULFIDE	1MBW07J51Q	ACTIB
HYPERICUM PERFORATUM	XK4IUX8MNB	ACTIB
LYCOPODIUM CLAVATUM SPORE	C88X29Y479	ACTIB
MERCURIUS SOLUBILIS	324Y4038G2	ACTIB
SALICYLIC ACID	O414PZ4LPZ	ACTIB
SILICON DIOXIDE	ETJ7Z6XBU4	ACTIB
ALLYLTHIOUREA	706IDJ14B7	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 46 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		620 mg	Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EFFERVESCENT / ORAL	96.5 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	GRANULE, FOR SUSPENSION / ORAL	512.5 mg/5ml		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / ORAL	530 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	GRANULE, FOR SUSPENSION / ORAL	512.5 mg/5ml		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / ORAL	530 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED PELLETS / ORAL	135.2 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, EXTENDED RELEASE / ORAL	120 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, DELAYED RELEASE / ORAL	231.84 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		620 mg	Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED PELLETS / ORAL	135.2 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / ORAL	1682 mg/15ml		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CONCENTRATE / ORAL	NA		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, DELAYED RELEASE / ORAL		160 mg	Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / ORAL	1682 mg/15ml		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EXTENDED RELEASE / ORAL	400 mg		Exact identifier — unii+route 36 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, ORALLY DISINTEGRATING / ORAL		1800 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, ORALLY DISINTEGRATING / ORAL		4364 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER, FOR SOLUTION / ORAL	NA		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CONCENTRATE / ORAL	NA		Exact identifier — unii+route 36 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	TABLET, ORALLY DISINTEGRATING / ORAL		7 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, ORALLY DISINTEGRATING / ORAL		4364 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED / ORAL	590 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EFFERVESCENT / ORAL	96.5 mg		Exact identifier — unii+route 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING / ORAL		187 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, EXTENDED RELEASE / ORAL	120 mg		Exact identifier — unii+route 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING / ORAL		187 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii+route 36 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	TABLET, ORALLY DISINTEGRATING / ORAL		7 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EXTENDED RELEASE / ORAL	400 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER, FOR SOLUTION / ORAL	NA		Exact identifier — unii+route 36 equally ranked IID candidates
COPOVIDONE	COPOVIDONE K25-31	D9C330MD8B	TABLET, ORALLY DISINTEGRATING / ORAL		35 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, DELAYED RELEASE / ORAL		160 mg	Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, DELAYED RELEASE / ORAL	231.84 mg		Exact identifier — unii+route 36 equally ranked IID candidates
COPOVIDONE	COPOVIDONE K25-31	D9C330MD8B	TABLET, ORALLY DISINTEGRATING / ORAL		35 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, ORALLY DISINTEGRATING / ORAL		1800 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, COATED / ORAL	332.05 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED / ORAL	590 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, COATED / ORAL	332.05 mg		Exact identifier — unii+route 36 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ring Relief	ARNICA MONTANA - CALCIUM SULFIDE - HYPERICUM PERFORATUM - LYCOPODIUM CLAVATUM SPORE - MERCURIUS SOLUBILIS - SALICYLIC ACID - SILICON DIOXIDE - ALLYLTHIOUREA -	TRP Company	aa2cd967-3c27-4afe-8751-7ea50ab62913	2025-12-15	Warnings	Exact identifier ndc (package): 17312-023-14 ndc (product): 17312-023 ndc11 (package): 17312002314 spl id: 4606551b-3bef-8c1b-e063-6394a90a0160 spl set id: aa2cd967-3c27-4afe-8751-7ea50ab62913

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.